News

Get to know what's happening behind the scenes.

Learn more

Featured

Blog

Read the latest on our blog. Let's Talk Innovation.

Social

Stay connected with us on social media.

twitter_logo_20px.jpg @JNJinnovation

Events

Press Releases

Read our latest news.

  • Accelerator Corporation Announces $7M Series A Investment in ApoGen Biotechnologies to Develop a New Class of Drugs Targeting Resistance to Cancer Therapy

  • Johnson & Johnson Innovation and Janssen Award U.S. $1.5 Million in Grants for World Without Disease QuickFire Challenge

    RMIT, Glyscend and Neurotrack each receive U.S. $500,000 research grant and offered residency at Johnson & Johnson Innovation | JLABS.

    NEW YORK, Nov. 14, 2016 — Johnson & Johnson Innovation LLC and Janssen Research & Development, LLC (Janssen) today announced multiple recipients of U.S. $500,000 grants and offers of residency at Johnson & Johnson Innovation | JLABS (JLABS) in the World Without Disease QuickFire Challenge. The announcement was made at the 2016 Partnering for Cures conference. The competition was the largest and most ambitious Johnson & Johnson Innovation QuickFire Challenge to date, representing an ongoing commitment to support diverse life science innovations and the development of integrated, cross-sector solutions to prevent, intercept and cure diseases.

    Download the PDF for the full press release.

  • ReVision Optics Raises $32 Million to Fund Expansion of U.S. Commercialization of Raindrop® Near Vision Inlay

Pages

Accelerators

Close
Neomed (Montreal)
7171 Frederick-Banting
Montreal, Quebec, CANADA H4S 1Z9
(514) 367 1212
mail@www.neomed.ca
www.neomed.ca
Your web browser is out of date. For the most optimal experience, please upgrade to the newest version of IE. Thank You.